Chemoinformaics analysis of Cannabigerovarinic-Acid
Molecular Weight | 332.44 | nRot | 8 |
Heavy Atom Molecular Weight | 304.216 | nRig | 9 |
Exact Molecular Weight | 332.199 | nRing | 1 |
Solubility: LogS | -3.197 | nHRing | 0 |
Solubility: LogP | 6.713 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 55.2782 |
nHD | 3 | BPOL | 28.9578 |
QED | 0.586 |
Synth | 2.835 |
Natural Product Likeliness | 2.191 |
NR-PPAR-gamma | 0.929 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.108 |
Pgp-sub | 0.007 |
HIA | 0.013 |
CACO-2 | -5.01 |
MDCK | 0.00000898 |
BBB | 0.039 |
PPB | 0.978111 |
VDSS | 1.932 |
FU | 0.0327706 |
CYP1A2-inh | 0.24 |
CYP1A2-sub | 0.188 |
CYP2c19-inh | 0.055 |
CYP2c19-sub | 0.06 |
CYP2c9-inh | 0.67 |
CYP2c9-sub | 0.416 |
CYP2d6-inh | 0.831 |
CYP2d6-sub | 0.136 |
CYP3a4-inh | 0.047 |
CYP3a4-sub | 0.035 |
CL | 3.933 |
T12 | 0.658 |
hERG | 0.029 |
Ames | 0.004 |
ROA | 0.369 |
SkinSen | 0.23 |
Carcinogencity | 0.144 |
EI | 0.051 |
Respiratory | 0.726 |
NR-Aromatase | 0.018 |
Antiviral | Yes |
Prediction | 0.593843 |